MYLAN P157 (Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base))
Pill with imprint MYLAN P157 is White, Elliptical/Oval and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base). It is supplied by Mylan Pharmaceuticals Inc.
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN P157
Metformin Hydrochloride and Pioglitazone Hydrochloride
- Imprint
- MYLAN P157
- Strength
- 850 mg / 15 mg (base)
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1575 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
povidone,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about metformin / pioglitazone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.